In8bioinc Stock Net Asset
INAB Stock | USD 0.99 0.05 4.81% |
In8bioInc fundamentals help investors to digest information that contributes to In8bioInc's financial success or failures. It also enables traders to predict the movement of In8bioInc Stock. The fundamental analysis module provides a way to measure In8bioInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to In8bioInc stock.
In8bioInc | Net Asset |
In8bioInc Company Net Asset Analysis
In8bioInc's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current In8bioInc Net Asset | 33.71 M |
Most of In8bioInc's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, In8bioInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In8bioInc Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for In8bioInc is extremely important. It helps to project a fair market value of In8bioInc Stock properly, considering its historical fundamentals such as Net Asset. Since In8bioInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of In8bioInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of In8bioInc's interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition |
In8bioInc Total Assets
Total Assets |
|
Based on the recorded statements, In8bioInc has a Net Asset of 33.71 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
In8bioInc Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses In8bioInc's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of In8bioInc could also be used in its relative valuation, which is a method of valuing In8bioInc by comparing valuation metrics of similar companies.In8bioInc is currently under evaluation in net asset category among related companies.
In8bioInc Institutional Holders
Institutional Holdings refers to the ownership stake in In8bioInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of In8bioInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing In8bioInc's value.Shares | Northern Trust Corp | 2023-12-31 | 49 K | Two Sigma Investments Llc | 2023-12-31 | 42.3 K | Laird Norton Tyee Trust Co | 2023-12-31 | 42.3 K | Overbrook Management Corp | 2023-12-31 | 33.8 K | Blackrock Inc | 2023-12-31 | 28.8 K | Renaissance Technologies Corp | 2023-12-31 | 19.6 K | Wela Strategies | 2024-03-31 | 18.5 K | Westside Investment Management, Inc. | 2023-12-31 | 14.5 K | Charles Schwab Investment Management Inc | 2023-12-31 | 13.1 K | Aigh Capital Management, Llc | 2023-12-31 | 4.1 M | Ensign Peak Advisors Inc | 2023-12-31 | 1.1 M |
In8bioInc Fundamentals
Return On Equity | -1.26 | ||||
Return On Asset | -0.57 | ||||
Current Valuation | 26.47 M | ||||
Shares Outstanding | 43.29 M | ||||
Shares Owned By Insiders | 15.70 % | ||||
Shares Owned By Institutions | 36.75 % | ||||
Number Of Shares Shorted | 512.02 K | ||||
Price To Book | 1.94 X | ||||
EBITDA | (27.84 M) | ||||
Net Income | (30.01 M) | ||||
Cash And Equivalents | 25.74 M | ||||
Cash Per Share | 1.37 X | ||||
Total Debt | 4.89 M | ||||
Debt To Equity | 0.07 % | ||||
Current Ratio | 9.08 X | ||||
Book Value Per Share | 0.58 X | ||||
Cash Flow From Operations | (23.34 M) | ||||
Short Ratio | 0.73 X | ||||
Earnings Per Share | (1.00) X | ||||
Target Price | 7.9 | ||||
Number Of Employees | 31 | ||||
Beta | -0.008 | ||||
Market Capitalization | 42.86 M | ||||
Total Asset | 33.71 M | ||||
Retained Earnings | (91.22 M) | ||||
Working Capital | 19.23 M | ||||
Net Asset | 33.71 M |
About In8bioInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze In8bioInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of In8bioInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of In8bioInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards In8bioInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, In8bioInc's short interest history, or implied volatility extrapolated from In8bioInc options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out In8bioInc Piotroski F Score and In8bioInc Altman Z Score analysis. For information on how to trade In8bioInc Stock refer to our How to Trade In8bioInc Stock guide.Note that the In8bioInc information on this page should be used as a complementary analysis to other In8bioInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for In8bioInc Stock analysis
When running In8bioInc's price analysis, check to measure In8bioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bioInc is operating at the current time. Most of In8bioInc's value examination focuses on studying past and present price action to predict the probability of In8bioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bioInc's price. Additionally, you may evaluate how the addition of In8bioInc to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is In8bioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bioInc. If investors know In8bioInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.00) | Return On Assets (0.57) | Return On Equity (1.26) |
The market value of In8bioInc is measured differently than its book value, which is the value of In8bioInc that is recorded on the company's balance sheet. Investors also form their own opinion of In8bioInc's value that differs from its market value or its book value, called intrinsic value, which is In8bioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bioInc's market value can be influenced by many factors that don't directly affect In8bioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.